XALUPRINE Oral suspension Ref.[8109] Active ingredients: Mercaptopurine

Source: European Medicines Agency (EU)  Revision Year: 2019  Publisher: Nova Laboratories Ireland Limited, 3<sup>rd</sup> Floor, Ulysses House, Foley Street, Dublin 1, D01 W2T2, Ireland

Product name and form

Xaluprine 20 mg/ml oral suspension.

Pharmaceutical Form

Oral suspension.

The suspension is pink to brown in colour.

Qualitative and quantitative composition

One ml of suspension contains 20 mg mercaptopurine (as monohydrate).

__Excipients with known effect:_ One ml of suspension contains 3 mg aspartame, 1 mg methyl hydroxybenzoate (as the sodium salt), 0.5 mg ethyl hydroxybenzoate (as the sodium salt) and sucrose (trace).

For the full list of excipients, see section 6.1.

Active Ingredient Description
Mercaptopurine

Mercaptopurine is an inactive pro-drug which acts as a purine antagonist but requires cellular uptake and intracellular anabolism to thioguanine nucleotides for cytotoxicity. The mercaptopurine metabolites inhibit de novo purine synthesis and purine nucleotide interconversions. The thioguanine nucleotides are also incorporated into nucleic acids and this contributes to the cytotoxic effects of the active substance.

List of Excipients

Xanthan gum
Aspartame (E951)
Concentrated raspberry juice
Sucrose
Sodium methyl parahydroxybenzoate (E219)
Sodium ethyl parahydroxybenzoate (E215)
Potassium sorbate (E202)
Sodium hydroxide
Purified water

Pack sizes and marketing

Amber type III glass bottle with tamper evident child-resistant closure (HDPE with expanded polyethylene liner) containing 100 ml of oral suspension.

Each pack contains one bottle, an HDPE bottle adaptor and 2 polyethylene dosing syringes (a purple syringe graduated to 1 ml and a white syringe graduated to 5 ml).

Marketing authorization holder

Nova Laboratories Ireland Limited, 3rd Floor, Ulysses House, Foley Street, Dublin 1, D01 W2T2, Ireland

Marketing authorization dates and numbers

EU/1/11/727/001

Date of first authorisation: 09 March 2012
Date of latest renewal: 18 November 2016

Drugs

Drug Countries
XALUPRINE Austria, Estonia, Finland, France, Ireland, Italy, Lithuania, Netherlands, Poland, United Kingdom

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.